Medical Robots Market Report

Global Medical Robots Market Size

The global medical robots market size was valued at USD 15.63 billion in 2025 and is anticipated to reach USD 18.94 billion in 2026 from USD 88.19 billion by 2034, growing at a CAGR of 21.2% during the forecast period from 2026 to 2034

Medical robots are a class of advanced electromechanical systems designed to assist in surgical procedures, rehabilitation, diagnostics, and hospital logistics, integrating artificial intelligence, real-time imaging, and precision actuation. These systems range from robotic arms in minimally invasive surgery to exoskeletons enabling post-stroke mobility and autonomous mobile robots transporting medical supplies within healthcare facilities.

MARKET DRIVERS

Rising Prevalence of Chronic Diseases Requiring Minimally Invasive Interventions

The escalating global burden of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders is accelerating the growth of the Medical Robots Market. According to the World Health Organization, non-communicable diseases account for 74% of all deaths worldwide, with surgical intervention required in over 40% of cancer cases. Robotic platforms like the da Vinci Surgical System enable oncologists to perform radical prostatectomies and colorectal resections with sub-millimeter accuracy, reducing blood loss and hospital stays. As per a 2023 study published in The Lancet Digital Health, robotic-assisted surgeries for early-stage endometrial cancer resulted in a 32% lower complication rate compared to traditional laparoscopy.

Expanding Geriatric Population and Demand for Rehabilitation Robotics

The demographic aging is fueling demand for robotic solutions in post-acute care, and mobility restoration in high-income countries is propelling the growth of the Medical Robots Market. As per the United Nations Department of Economic and Social Affairs, the number of individuals aged 65 and over is projected to reach 1.5 billion by 2050. Exoskeleton robots such as ReWalk and EksoGT have demonstrated efficacy in gait training, with clinical trials at the Swiss Paraplegic Centre showing a 41% improvement in walking speed among stroke survivors after eight weeks of robot-assisted therapy.

MARKET RESTRAINTS

High Capital Expenditure and Limited Reimbursement Frameworks

The substantial upfront costs and inconsistent insurance coverage in middle- and low-income countries are restricting the growth of the Medical Robots Market. Medicare covers robotic-assisted prostatectomy but does not provide additional payment for the robotic component, which disincentivizes hospitals from investing in new systems. As per a 2023 analysis by the National Institute for Health Care Management, only 38% of robotic procedures in cardiology and general surgery received full reimbursement across private insurers.

Shortage of Trained Clinical Personnel and Standardized Training Protocols

The lack of certified robotic surgeons and technicians impedes widespread implementation is also hampering the growth of the Medical Robots Market. According to the Royal College of Surgeons, fewer than 15% of general surgeons in the UK have completed formal robotic surgery certification, despite the National Health Service’s investment in robotic platforms. In India, where only 120 surgeons are accredited for robotic procedures despite a population of 1.4 billion, the disparity is even more pronounced. According to a 2022 study in JAMA Surgery, surgeons required a minimum of 25 supervised procedures to achieve technical competence in robotic hysterectomy.

MARKET OPPORTUNITIES

Integration of Artificial Intelligence and Machine Learning for Autonomous Surgical Planning

The integration of medical robotics with artificial intelligence to enhance preoperative planning, intraoperative decision-making, and outcome prediction which is levelling up the growth of the Medical Robots Market. AI algorithms trained on vast surgical datasets can generate patient-specific procedural roadmaps, optimizing instrument pathways and reducing operative time. As per a 2023 publication in Nature Biomedical Engineering, an AI-driven module integrated with the da Vinci system reduced instrument collisions by 29% during mock prostatectomies by predicting anatomical obstructions in real time. Moreover, companies like Virtual Surgical Planning (VSP) by 3D Systems now offer AI-powered segmentation of CT and MRI scans to guide robotic bone cutting in orthopedic and craniofacial surgeries. The Mayo Clinic reported a 22% improvement in implant alignment accuracy in robotic knee arthroplasty when AI-assisted planning was employed.

Expansion of Tele-Robotics in Remote and Underserved Regions

Tele-robotic surgery enables specialists to perform procedures from distant locations by offering a viable solution to geographic disparities in surgical access, which also accelerates the growth of the Medical Robots Market. In 2023, China conducted over 300 telesurgical procedures using the MicroPort Hugo platform, linking urban hospitals with rural clinics across Xinjiang and Yunnan provinces, as documented by the Chinese Medical Association. Similarly, the European Space Agency collaborated with healthcare providers to test robotic surgery controls from a simulated satellite delay environment, achieving successful suturing with a 500-millisecond lag.

MARKET CHALLENGES

Cybersecurity Vulnerabilities in Networked Robotic Systems

Hospital networks are directly connected to the internet, where it is easy to get exposed to cyber threats that could compromise patient safety and data integrity. This factor is acting as a major barrier to the growth of the Medical Robots Market. A 2023 report by the U.S. Food and Drug Administration identified 47 cybersecurity-related recalls of medical devices, with robotic systems reliance on real-time software updates and remote access features. Researchers at the University of California, San Diego demonstrated in a controlled environment that a simulated ransomware attack on a robotic arm could disrupt instrument calibration, leading to unintended tissue contact. The integration of third-party software and legacy IT systems in hospitals further amplifies attack surfaces.

Regulatory Heterogeneity and Delayed Approval Pathways for Advanced Robotic Platforms

The divergent regulatory frameworks are also hampering the growth of the Medical Robots Market. While the U.S. FDA operates a rigorous premarket approval (PMA) process for high-risk robotic devices, the European Union’s transition from the Medical Device Directive to the Medical Device Regulation (MDR) has caused delays in CE marking renewals. According to the European Commission, over 30% of Class III medical devices faced approval delays exceeding 18 months under the new MDR regime as of 2023. In emerging markets such as Brazil and Indonesia, unclear classification guidelines for AI-integrated robots result in prolonged review cycles.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

The surgical robots segment was the largest and held 56.4% of the medical robotics market share in 2025, with their integration into high-volume procedures such as urological, gynecological, and cardiothoracic surgeries. The da Vinci Surgical System by Intuitive Surgical alone has been utilized in over 1.2 million procedures annually worldwide, according to data from the U.S. National Library of Medicine. Additionally, the precision of robotic arms is capable of filtering hand tremors and scaling movements at a 5:1 ratio that enables access to anatomically confined spaces by enhancing outcomes in nerve-sparing prostatectomies and transoral surgeries.

The rehabilitation robotic systems segment is growing lucratively with an expected CAGR of 14.3% during the forecast period, with the rising incidence of neurological impairments and the shift toward outpatient and home-based therapy models. Furthermore, wearable exoskeletons such as ReWalk and HAL by Cyberdyne have gained regulatory approval in Japan and Germany for community ambulation, enabling long-term mobility support. The integration of real-time biofeedback and adaptive algorithms allows these systems to personalize therapy intensity, which significantly improves patient adherence and functional outcomes.

By Application Insights

Based on application, the neurological segment had the largest share of the global market in 2025 and is expected to showcase a healthy CAGR during the forecast period. The growth of the segment is primarily driven by the growing neurological disorders such as depression and Alzheimer’s and technological developments for the NeuroMate system hardware and software in the field of robotic systems, with improvements made in the scope of ergonomics.

The orthopedics robotics segment held a noteworthy share of the global market in 2024 and is estimated to register a promising growth rate during the forecast period. The growing number of musculoskeletal conditions, such as rheumatoid arthritis, low back pain, osteoarthritis, and osteoporosis, is propelling segmental growth.

The laparoscopy segment is expected to do well over the forecast period due to the ease of handling the devices; these are mainly designed to meet the surgeons' requirements.

REGIONAL ANALYSIS

North America was the largest contributor by accounting for 42.3% of the global medical robots market share in 2025, with the highest concentration of robotic surgical installations and innovation hubs. As of 2024, over 3,200 da Vinci systems are operational across U.S. hospitals, facilitating more than 1.1 million robotic procedures annually, as documented by the American College of Surgeons. The country’s robust reimbursement framework for robotic-assisted prostatectomy and hysterectomy incentivizes adoption, while the presence of leading manufacturers such as Intuitive Surgical and Stryker ensures rapid technology diffusion.

Europe was ranked second by holding 28.3% of the Medical Robots Market share in 2024. The European market is characterized by strong public healthcare investment in precision medicine and digital surgery. Germany operates over 450 robotic surgical units, the highest in Europe, supported by statutory health insurance coverage for specific robotic interventions, as reported by the German Federal Joint Committee.

The Asia-Pacific medical robots market growth is likely to be driven by with the most rapid expansion, driven by rising healthcare expenditures and government modernization initiatives. Japan leads the regional adoption, with over 300 robotic surgery systems installed by 2024, and the national health insurance system covering 14 distinct robotic procedures, according to Japan’s Ministry of Health, Labour and Welfare.

Latin America and Middle East and Africa are substantially to grow with a steady pace during the forecast period. Brazil is emerging as the primary adopter due to its relatively advanced private healthcare infrastructure. The country has over 80 operational robotic surgical systems, concentrated in São Paulo, Rio de Janeiro, and Brasília, as per the Brazilian Society of Urology. Robotic prostatectomy has become a standard of care in private clinics, with a 22% annual increase in procedures between 2021 and 2023. Public-private partnerships, such as the collaboration between the Albert Einstein Israelite Hospital and the São Paulo Research Foundation, have facilitated training and technology access.

The Middle East and Africa Medical Robots market with Saudi Arabia and the United Arab Emirates leading in medical robotics adoption. King Faisal Specialist Hospital in Riyadh performs over 1,500 robotic surgeries annually, primarily in oncology and urology. The UAE has established robotic centers of excellence in Dubai and Abu Dhabi, with Cleveland Clinic Abu Dhabi performing the region’s first robotic mitral valve repair in 2023. Additionally, the Gulf Cooperation Council’s harmonization of medical device regulations is streamlining approvals by enabling faster market entry for international manufacturers seeking to expand in this high-potential region.

COMPETITIVE LANDSCAPE

The competition in the Medical Robots Market is intensifying as global leaders face emerging regional innovators and evolving clinical expectations. While established players dominate through technological maturity and extensive clinical data, new entrants from China, India, and South Korea are introducing cost-optimized systems tailored to local healthcare infrastructures. Differentiation increasingly hinges on precision, adaptability, and integration with hospital digital ecosystems. The race to incorporate artificial intelligence, predictive analytics, and remote operation capabilities is reshaping competitive dynamics.

KEY MARKET PLAYERS

Some of the notable companies in the global medical robots market profiled in the report are

• Intuitive Surgical Inc.
• Stryker Corporation
• Hocoma AG
• Mazor Robotics Ltd
• Hansen Medical Inc.
• Accuray Incorporated
• Omnicell Inc.
• Arxium
• EKSO Bionics Holdings Inc.
• Kirby Lester LLC.

Top Players in the Medical Robots Market

Intuitive Surgical

Intuitive Surgical has established a foundational presence in the Asia-Pacific medical robotics landscape through its da Vinci Surgical System, which is widely adopted in major hospitals across Japan, South Korea, Australia, and China. The company has intensified its regional engagement by collaborating with academic medical centers to conduct clinical training programs and surgical outcome studies tailored to Asian patient anatomies. In 2023, Intuitive partnered with Tokyo Women’s Medical University to launch a robotic surgery excellence center, enhancing surgeon certification and procedural standardization. It has also localized customer support by establishing technical service hubs in Singapore and Shanghai, which is reducing downtime and improving system uptime.

Medtronic
Medtronic has strategically expanded its footprint in the Asia-Pacific market through its Hugo™ Robotic-Assisted Surgery (RAS) platform, positioning it as a cost-competitive and modular alternative to established systems. The company has secured regulatory approvals in Australia, South Korea, and India, and initiated multicenter clinical trials in Thailand and Taiwan to validate Hugo’s efficacy in urological and gynecological procedures. In 2023, Medtronic launched a mobile training unit in India to provide hands-on robotic surgery workshops for surgeons in tier-2 and tier-3 cities, addressing the regional skills gap. Additionally, the company formed a distribution alliance with local healthcare providers in Indonesia to improve market access. Medtronic also integrated AI-driven analytics into the Hugo platform, enhancing instrument tracking and surgical workflow efficiency, which has strengthened its appeal among technologically advanced hospitals.

Cyberdyne Inc.

Cyberdyne Inc., a Japanese pioneer in neurologically controlled robotics, has significantly influenced the Asia-Pacific rehabilitation robotics sector through its Hybrid Assistive Limb (HAL) exoskeleton. The company’s deep integration within Japan’s national healthcare system allows HAL to be used in over 200 clinical and rehabilitation facilities, supported by public insurance reimbursement.

Top Strategies Used by the Key Market Participants

Key players in the medical robots market are employing strategies such as technology localization, strategic partnerships, regulatory navigation, workforce training, and platform modularization to strengthen their global positions. Companies are adapting robotic systems to regional clinical practices and patient demographics to enhance adoption. Collaborations with hospitals and universities facilitate clinical validation and surgeon education. Expanding reimbursement eligibility through engagement with health authorities accelerates market access. Investment in mobile training units and simulation labs addresses the shortage of skilled operators. Modular designs that allow incremental upgrades reduce initial investment barriers. Additionally, integrating AI and real-time analytics enhances system intelligence and procedural efficiency, differentiating platforms in a competitive landscape increasingly focused on outcomes and cost-effectiveness.

RECENT HAPPENINGS IN THE MARKET

• In March 2023, Intuitive Surgical launched a robotic surgery training center in collaboration with Tokyo Women’s Medical University by aiming to enhance surgeon proficiency and expand clinical applications of the da Vinci system in Japan.
• In July 2023, Medtronic introduced the Hugo™ RAS platform in India with a mobile training unit by enabling hands-on robotic surgery education for clinicians across underserved urban and rural hospitals.
• In November 2023, Cyberdyne Inc. initiated a clinical pilot program at Changi General Hospital in Singapore to evaluate the effectiveness of its HAL exoskeleton in geriatric mobility rehabilitation.
• In January 2024, Intuitive Surgical secured reimbursement approval from Japan’s National Health Insurance for robotic-assisted lung resection, which is broadening the clinical scope of da Vinci procedures in thoracic surgery.
• In May 2024, Medtronic expanded its AI integration in the Hugo platform by introducing real-time instrument tracking and surgical workflow analytics to improve procedural efficiency and safety in operating rooms across the Asia-Pacific.

MARKET SEGMENTATION

This research report on the global medical robots market has been segmented & sub-segmented based on product, application, and region.

By Product

• Surgical Robots
  • Laparoscopy Robotic Systems
  • Orthopedic Robotic Systems
  • Neurosurgical Robotic Systems
  • Steerable Robotic Systems
• Rehabilitation Robotic Systems
  • Therapeutic Robotic Systems
  • Assistive Robotic Systems
  • Prosthetic Robotic Systems
  • Orthotic Robotic Systems
  • Exoskeleton Robotic Systems
• Non-Invasive Radiosurgery Robotic Systems
• Hospital And Pharmacy Robotic Systems
  • Pharmacy Robotic Systems
  • Iv Robotic Systems
  • Telemedicine Robots

By Application

• Laparoscopy
• Orthopedics
• Neurology
• Special Education

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa